John M. Sheldon
YOU?
Author Swipe
View article: PS1427 THE SIGNIFICANCE OF UNEXPECTED PHARMACOKINETICS OF DARATUMUMAB DURING LONG‐TERM MONTHLY TREATMENT FOR MYELOMA
PS1427 THE SIGNIFICANCE OF UNEXPECTED PHARMACOKINETICS OF DARATUMUMAB DURING LONG‐TERM MONTHLY TREATMENT FOR MYELOMA Open
Background: Daratumumab, a drug used in the treatment of multiple myeloma appears as a small IgGK band on serum protein electrophoresis that can be quantified alongside any monoclonal proteins that are present in a patient's serum. Aims: T…